|
Cardio-renal physiology/pathophysiology
Citations 1-10 of 28 total displayed.
|
Most recent content
(18 Jun 2009):
|
- Articles
Reversible Oxidative Modification. A Key Mechanism of Na+-K+ Pump Regulation
- Gemma A. Figtree, Chia-Chi Liu, Stephanie Bibert, Elisha J. Hamilton, Alvaro Garcia, Caroline N. White, Karin K.M. Chia, Flemming Cornelius, Kaethi Geering, and Helge H. Rasmussen
Circ. Res. published June 18, 2009, doi:10.1161/CIRCRESAHA.109.199547
[Abstract]
|
Past content
(since Mar 2000):
|
- Cellular Biology
Role of Oxidant Stress on AT1 Receptor Expression in Neurons of Rabbits With Heart Failure and in Cultured Neurons
- Dongmei Liu, Lie Gao, Shyamal K. Roy, Kurtis G. Cornish, and Irving H. Zucker
Circ. Res. 103: 186 -193; published online before print as doi:10.1161/CIRCRESAHA.108.179408
[Abstract]
[Full text]
- Articles
The Role of Oxidant Stress on AT1 Receptor Expression in Neurons of Rabbits With Heart Failure and in Cultured Neurons
- Dongmei Liu, Lie Gao, Shyamal K. Roy, Kurtis G. Cornish, and Irving H. Zucker
Circ. Res. published June 19, 2008, doi:10.1161/CIRCRESAHA.108.179408
[Abstract]
- Integrative Physiology
Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction
- Tetsuro Shishido, Chang-Hoon Woo, Bo Ding, Carolyn McClain, Carlos A. Molina, Chen Yan, Jay Yang, and Jun-ichi Abe
Circ. Res. 102: 1416 -1425; published online before print as doi:10.1161/CIRCRESAHA.107.168138
[Abstract]
[Full text]
- Articles
Association of MEK5 With ERK5, but not ERK5 Kinase Activation, Inhibits Small Ubiquitin-Related Modification of ERK5 Kinase (ERK5-SUMOylation), and Prevents Diabetes-Mediated Exacerbation of Left Ventricular Dysfunction After Myocardial Infarction
- Tetsuro Shishido, Chang-Hoon Woo, Bo Ding, Carolyn McClain, Carlos A. Molina, Chen Yan, Jay Yang, and Jun-ichi Abe
Circ. Res. published May 8, 2008, doi:10.1161/CIRCRESAHA.107.168138
[Abstract]
- Reports
Beneficial Effect of the Central Nervous System β-Adrenoceptor Blockade on the Failing Heart
- Andrey Gourine, Svetlana I. Bondar, K. Michael Spyer, and Alexander V. Gourine
Circ. Res. 102: 633 -636; published online before print as doi:10.1161/CIRCRESAHA.107.165183
[Abstract]
[Full text]
- Articles
Beneficial Effect of the Central Nervous System  -Adrenoceptor Blockade on the Failing Heart
- Andrey Gourine, Svetlana I. Bondar, K. Michael Spyer, and Alexander V. Gourine
Circ. Res. published March 6, 2008, doi:10.1161/CIRCRESAHA.107.165183
[Abstract]
- Reviews
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
- David A. Kass, Hunter C. Champion, and Joseph A. Beavo
Circ. Res. 2007; 101: 1084-1095, doi:10.1161/CIRCRESAHA.107.162511
[Abstract]
[Full text]
- Integrative Physiology
Inhibition of Glycogen Synthase Kinase 3ß During Heart Failure Is Protective
- Shinichi Hirotani, Peiyong Zhai, Hideharu Tomita, Jonathan Galeotti, Juan Pablo Marquez, Shumin Gao, Chull Hong, Atsuko Yatani, Jesús Avila, and Junichi Sadoshima
Circ. Res. 101: 1164 -1174; published online before print as doi:10.1161/CIRCRESAHA.107.160614
[Abstract]
[Full text]
- Articles
Inhibition of Glycogen Synthase Kinase 3 During Heart Failure Is Protective
- Shinichi Hirotani, Peiyong Zhai, Hideharu Tomita, Jonathan Galeotti, Juan Pablo Marquez, Shumin Gao, Chull Hong, Atsuko Yatani, Jesús Avila, and Junichi Sadoshima
Circ. Res. published September 27, 2007, doi:10.1161/CIRCRESAHA.107.160614
[Abstract]
|
|
